BSECompany Update11 Aug 2026 · 11 Aug 2026, 09:02 pm
Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you ....
Gaudium IVF and Women Health Ltd · 544709
✦ AI SummaryResults
Gaudium IVF and Women Health Ltd has scheduled an earnings conference call to discuss its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The call is scheduled for August 14, 2026, at 2:00 P.M. IST. The company has provided details of the call, including a pre-registration link and international toll-free numbers.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gaudium IVF and Women Health Ltd - 544709 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
bcd51f9e-519b-4357-9969-5341bf97b705.pdf
View document text
gaudium® IVF
Delivering Motherhood Dreams
August 11, 2026
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Exchange Plaza, C-1, Block G, Bandra Kurla
Towers, Dalal Street, Fort, Complex, Bandra (E), Mumbai — 400051,
Mumbai — 400001, Maharashtra Maharashtra
Scrip Code — 544709 Symbol - GAUDIUMIVF
ISIN: INEOP8B01020 ISIN: INEOP8B01020
Subject: Intimation of Q1 & FY 2027 Earnings Call
Ref: Regulation 30 of Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015
Dear Sir/Ma’am
Pursuant to Regulation 30 read with Schedule IIT of the Securities and Exchange Board of India
(Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that
an Earnings Conference Call to discuss the Unaudited Standalone and Consolidated Financial
Results of the Company for the quarter ended June 30, 2026, is scheduled for Friday, August 14,
2026, at 02:00 P.M. IST.
The details pertaining to the said call are enclosed herewith and the same will also be available on
the website of the Company at https://www.gaudiumivfcentre.com/
We request you to kindly take the same on record.
Thanking you,
Yours faithfully.
For and on behalf of Gaudium IVF and Women Health Limited
(Formerly known as Gaudium IVF and Women Health Private Limited)
Naveen Kumar
Company Secretary and Compliance Officer
Membership No: A69788
Encl: a/a
Gaudium IVF and Women Health Limited (Formerly known as Gaudium IVF and Women Health Pvt. Ltd.)
Registered Office : B1/51, Janakpuri, New Delhi- 110058 | Ph: 011-4885 8585
CIN : L85100DL2015PLC278296 Email : info@gaudiumivfcentre.com Website : www.gaudiumivfcentre.com -[E]3
The Management of Gaudium IVF and Women
Health Limited Invites you to the
Q1 FY27
To discuss the performance for the quarter
ended June 30, 2026
Date: Friday, 14th August 2026 Time: 02:00 PM IST
Option 1
Pre- registration link Click Here
Direct Call
Universal Access Number
+91 22 6280 1102 / +91 22 7115 8003
Option 2
International Toll-Free Numbers
Dial-in through
USA 18667462133
Operator
Assistance UK 08081011573
Hong Kong 800964448
Singapore 8001012045
Participants are requested to dial-in few minutes in advance
Management Participants
Dr. Manika Khanna, Mr. Vishad Khanna, Mr. Rakesh K. Sharma
Chairperson & Managing Director Non-Executive Director Chief Financial Officer
For more information, please contact:
Rushabh Shah / Anand Venugopal
Mobile: +91 8082180182 / +91 7021852071
Email id: rushabh.shah@adfactorspr.com /
anand.venugopal@adfactorspr.com